Glomerulonephritis, IGA
Welcome,         Profile    Billing    Logout  
 18 Companies   19 Products   19 Products   22 Mechanisms of Action   0 Trials   61 News 


12»
  • ||||||||||  losartan potassium / Generic mfg.
    Trial completion, Trial completion date:  Efficacy and Safety of Losartan in Children With Ig A Nephropathy (clinicaltrials.gov) -  Oct 11, 2018   
    P3,  N=37, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Apr 2017
  • ||||||||||  hydroxychloroquine / Generic mfg.
    Trial completion, Trial completion date, Trial initiation date, Trial primary completion date:  A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy (clinicaltrials.gov) -  Feb 5, 2018   
    P2,  N=60, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Apr 2017 Recruiting --> Completed | Trial primary completion date: Aug 2018 --> Jan 2018 | Trial completion date: Aug 2018 --> Jan 2018 | Initiation date: Aug 2016 --> Sep 2016
  • ||||||||||  bortezomib / Generic mfg.
    Trial completion, Enrollment change:  Pilot Study of Velcade® in IgA Nephropathy (clinicaltrials.gov) -  Aug 10, 2017   
    P4,  N=11, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=15 --> 11
  • ||||||||||  losartan potassium / Generic mfg.
    Enrollment closed, Trial primary completion date:  Efficacy and Safety of Losartan in Children With Ig A Nephropathy (clinicaltrials.gov) -  Jul 17, 2017   
    P3,  N=37, Active, not recruiting, 
    Recruiting --> Completed | N=15 --> 11 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt
    Enrollment change, Trial withdrawal:  Acthar on Proteinuria in IgA Nephropathy Patients (clinicaltrials.gov) -  Apr 5, 2017   
    P4,  N=0, Withdrawn, 
    Trial primary completion date: Dec 2018 --> Mar 2017 N=26 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  Trial completion:  NIDOCIGA: IgA Nephropathy, Lymphocyte Homing and IgA Class Switch (clinicaltrials.gov) -  Aug 22, 2016   
    P=N/A,  N=72, Completed, 
    Recruiting --> Completed | Initiation date: Dec 2010 --> Mar 2011 | Trial primary completion date: Dec 2013 --> Aug 2016 Recruiting --> Completed
  • ||||||||||  bortezomib / Generic mfg.
    Enrollment change, Trial primary completion date:  Pilot Study of Velcade® in IgA Nephropathy (clinicaltrials.gov) -  Jan 22, 2016   
    P4,  N=15, Recruiting, 
    Recruiting --> Active, not recruiting | N=20 --> 5 N=10 --> 15 | Trial primary completion date: Jul 2016 --> Jul 2017
  • ||||||||||  losartan potassium / Generic mfg.
    Enrollment open:  Efficacy and Safety of Losartan in Children With Ig A Nephropathy (clinicaltrials.gov) -  Nov 19, 2015   
    P3,  N=37, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Oct 2015 Not yet recruiting --> Recruiting
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    Trial completion:  Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy (clinicaltrials.gov) -  Oct 27, 2015   
    P4,  N=54, Completed, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Completed
  • ||||||||||  Tavalisse (fostamatinib) / Rigel
    Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date:  Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy (clinicaltrials.gov) -  Oct 23, 2015   
    P2,  N=0, Withdrawn, 
    Active, not recruiting --> Completed N=25 --> 0 | Initiation date: Jun 2015 --> Sep 2015 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2017 --> Sep 2015
  • ||||||||||  H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt
    New P4 trial:  Acthar on Proteinuria in IgA Nephropathy Patients (clinicaltrials.gov) -  Mar 7, 2015   
    P4,  N=26, Recruiting, 
  • ||||||||||  bortezomib / Generic mfg.
    Trial primary completion date:  Pilot Study of Velcade® in IgA Nephropathy (clinicaltrials.gov) -  Jan 30, 2015   
    P4,  N=10, Recruiting, 
    Withdrawn --> Terminated; low-rate of enrollment Trial primary completion date: Jul 2015 --> Jul 2016
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    Enrollment closed, Trial primary completion date:  Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy (clinicaltrials.gov) -  Nov 20, 2014   
    P4,  N=54, Active, not recruiting, 
    Trial primary completion date: Jul 2015 --> Jul 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2014 --> Sep 2015
  • ||||||||||  mycophenolate mofetil / Generic mfg.
    Trial termination:  Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (clinicaltrials.gov) -  Oct 2, 2014   
    P3,  N=184, Terminated, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2014 --> Sep 2015 Completed --> Terminated; DSMB recommended stopping the trial because of lack of effect.
  • ||||||||||  bortezomib / Generic mfg.
    Trial primary completion date:  Pilot Study of Velcade® in IgA Nephropathy (clinicaltrials.gov) -  Jun 12, 2014   
    P4,  N=10, Recruiting, 
    Trial primary completion date: Jun 2014 --> Dec 2015 Trial primary completion date: Jul 2014 --> Jul 2015